Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release

Biomaterials

Volumn 30, Issue 36, 2009, Pages 6964-6975

  Jha, Amit K ^a   Yang, Weidong ^a   Kirn Safran, Catherine B ^a   Farach Carson, Mary C ^a   Jia, Xinqiao ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Bone morphogenetic protein 2; Chondrogenic differentiation; Controlled release; Hyaluronic acid; Hydrogel particles; Perlecan domain I

Indexed keywords

BONE MORPHOGENETIC PROTEIN-2; CHONDROGENIC DIFFERENTIATION; CONTROLLED RELEASE; HYALURONIC ACID; PERLECAN DOMAIN I;

AMINATION; AMINES; AMINO ACIDS; BIOMIMETICS; BONE; CARTILAGE; CELL CULTURE; CELLS; EMULSIFICATION; EMULSION POLYMERIZATION; ETHYLENE; ETHYLENE GLYCOL; FUNCTIONAL GROUPS; FUNCTIONAL POLYMERS; HYDRAULIC STRUCTURES; HYDROXYLATION; LIGAMENTS; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; PROTEINS;

HYDROGELS;

AGGRECAN; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID; LYSINE; MACROGOL; PERLECAN; PERLECAN DOMAIN PROTEIN 1; UNCLASSIFIED DRUG;

AMINATION; ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRIX; HYDROGEL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; PROTEIN TARGETING;

ANIMALS; BIOMIMETICS; BONE MORPHOGENETIC PROTEIN 2; CARTILAGE; CELL DIFFERENTIATION; CELL LINE; CHONDROGENESIS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; HYALURONIC ACID; HYDROGELS; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PARTICLE SIZE;

EID: 70350188311     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.09.009     Document Type: Article

References (53)

1. Goldring M.B., and Goldring S.R. Osteoarthritis. J Cell Physiol 213 (2007) 626-634
2. Goldring M.B., Tsuchimochi K., and Ijiri K. The control of chondrogenesis. J Cell Biochem 97 (2006) 33-44
3. Quintana L., Nieden N.I.Z., and Semino C.E. Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering. Tissue Eng Part B Rev 15 (2009) 29-41
4. Hall B.K., and Miyake T. All for one and one for all: condensations and the initiation of skeletal development. Bioessays 22 (2000) 138-147
5. Bessa P.C., Casal M., and Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2 (2008) 81-96
6. Farach-Carson M.C., Hecht J.T., and Carson D.D. Heparan sulfate proteoglycans: key players in cartilage biology. Crit Rev Eukaryot Gene Expr 15 (2005) 29-48
7. Farach-Carson M.C., and Carson D.D. Perlecan-a multifunctional extracellular proteoglycan scaffold. Glycobiology 17 (2007) 897-905
8. Takada T., Katagiri T., Ifuku M., Morimura N., Kobayashi M., Hasegawa K., et al. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 278 (2003) 43229-43235
9. Ruppert R., Hoffmann E., and Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 237 (1996) 295-302
10. Sahiner N., Jha A.K., Nguyen D., and Jia X.Q. Fabrication and characterization of cross-linkable hydrogel particles based on hyaluronic acid: potential application in vocal fold regeneration. J Biomater Sci Polym Ed 19 (2008) 223-243
11. Jha A.K., Hule R.A., Jiao T., Teller S.S., Clifton R.J., Duncan R.L., et al. Structural analysis and mechanical characterization of hyaluronic acid-based doubly cross-linked networks. Macromolecules 42 (2009) 537-546
12. Jia X.Q., Burdick J.A., Kobler J., Clifton R.J., Rosowski J.J., Zeitels S.M., et al. Synthesis and characterization of in situ cross-linkable hyaluronic acid-based hydrogels with potential application for vocal fold regeneration. Macromolecules 37 (2004) 3239-3248
13. Garg H.G., and Hales C.A. Chemistry and biology of hyaluronan. 1st ed. (2004), Elsevier Ltd., Oxford
14. Knudson C.B., and Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis and disease. FASEB J 7 (1993) 1233-1241
15. Laurent T.C., and Fraser J.R.E. Hyaluronan. FASEB J 6 (1992) 2397-2404
16. Knudson C.B., and Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 12 (2001) 69-78
17. Jia X.Q., Yeo Y., Clifton R.J., Jiao T., Kohane D.S., Kobler J.B., et al. Hyaluronic acid-based microgels and microgel networks for vocal fold regeneration. Biomacromolecules 7 (2006) 3336-3344
18. Jia X.Q., Colombo G., Padera R., Langer R., and Kohane D.S. Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials 25 (2004) 4797-4804
19. Matsuda S., Iwata H., Se N., and Ikada Y. Bioadhesion of gelatin films crosslinked with glutaraldehyde. J Biomed Mater Res 45 (1999) 20-27
20. Yang W.D., Gomes R.R., Alicknavitch M., Farach-Carson M.C., and Carson D.D. Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds. Tissue Eng 11 (2005) 76-89
21. Costell M., Mann K., Yamada Y., and Timpl R. Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides. Eur J Biochem 243 (1997) 115-121
22. Kelley L.A., and Sternberg M.J.E. Protein structure prediction on the web: a case study using the Phyre server. Nat Protoc 4 (2009) 363-371
23. Wu X.S., Hoffman A.S., and Yager P. Synthesis and characterization of thermally reversible macroporous poly(N-isopropylacrylamide) hydrogels. J Polym Sci Polym Chem 30 (1992) 2121-2129
24. Bert J.L., Pearce R.H., Mathieson J.M., and Warner S.J. Characterization of collagenous meshworks by volume exclusion of dextrans. Biochem J 191 (1980) 761-768
25. Yang W.D., Gomes R.R., Brown A.J., Burdett A.R., Alicknavitch M., Farach-Carson M.C., et al. Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices. Tissue Eng 12 (2006) 2009-2024
26. Farach-Carson M.C., Brown A.J., Lynam M., Safran J.B., and Carson D.D. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation. Matrix Biol 27 (2008) 150-160
27. Roughley P.J., and Lee E.R. Cartilage proteoglycans-structure and potential functions. Microsc Res Tech 28 (1994) 385-397
28. Lin Z., Willers C., Xu J.A., and Zheng M.H. The chondrocyte: biology and clinical application. Tissue Eng 12 (2006) 1971-1984
29. Babensee J.E., McIntire L.V., and Mikos A.G. Growth factor delivery for tissue engineering. Pharm Res 17 (2000) 497-504
30. Nimni M.E. Polypeptide growth factors: targeted delivery systems. Biomaterials 18 (1997) 1201-1225
31. Mumper R.J., Hoffman A.S., Puolakkainen P.A., Bouchard L.S., and Gombotz W.R. Calcium-alginate beads for the oral delivery of transforming growth factor-β1 (TGF-β1): stabilization of TGF-b1 by the addition of polyacrylic acid within acid-treated beads. J Control Release 30 (1994) 241-251
32. Peters M.C., Isenberg B.C., Rowley J.A., and Mooney D.J. Release from alginate enhances the biological activity of vascular endothelial growth factor. J Biomater Sci Polym Ed 9 (1998) 1267-1278
33. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., and Hubbell J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 72 (2001) 101-113
34. Shen Y.H., Shoichet M.S., and Radisic M. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater 4 (2008) 477-489
35. Sakiyama-Elbert S.E., and Hubbell J.A. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 65 (2000) 389-402
36. Chung H.J., Kim H.K., Yoon J.J., and Park T.G. Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. Pharm Res 23 (2006) 1835-1841
37. Blanquaert F., Barritault D., and Caruelle J.P. Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression. J Biomed Mater Res 44 (1999) 63-72
38. French M.M., Gomes R.R., Timpl R., Hook M., Czymmek K., Farach-Carson M.C., et al. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. J Bone Miner Res 17 (2002) 48-55
39. French M.M., Smith S.E., Akanbi K., Sanford T., Hecht J., Farach-Carson M.C., et al. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol 145 (1999) 1103-1115
40. Hegewald A.A., Ringe J., Bartel J., Kruger I., Notter M., Barnewitz D., et al. Hyaluronic acid and autologous synovial fluid induce chondrogenic differentiation of equine mesenchymal stem cells: a preliminary study. Tissue Cell 36 (2004) 431-438
41. Knudson W., and Loeser R.F. CD44 and integrin matrix receptors participate in cartilage homeostasis. Cell Mol Life Sci 59 (2002) 36-44
42. Esposito E., Menegatti E., and Cortesi R. Hyaluronan-based microspheres as tools for drug delivery: a comparative study. Int J Pharm 288 (2005) 35-49
43. Toida T., Yoshida H., Toyoda H., Koshishi I., Imanari T., Hileman R.E., et al. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem J 322 (1997) 499-506
44. Bancroft J.D., and Gamble M. Theory and practice of histological techniques. 5th ed (2002), Harcourt Publishers Limited, London
45. Winn S.R., Uludag H., and Hollinger J.O. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 31 (1998) 303-318
46. Crouzier T., Ren K., Nicolas C., Roy C., and Picart C. Layer-by-layer films as a biomimetic reservoir for rhBMP-2 delivery: controlled differentiation of myoblasts to osteoblasts. Small 5 (2009) 598-608
47. Bowman M.C., Ballard T.E., Ackerson C.J., Feldheim D.L., Margolis D.M., and Melander C. Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc 130 (2008) 6896-6897
48. Mammen M., Choi S.K., and Whitesides G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 37 (1998) 2755-2794
49. Lee J.S., Go D.H., Bae J.W., Lee S.J., and Park K.D. Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor. J Control Release 117 (2007) 204-209
50. Casper C.L., Yamaguchi N., Kiick K.L., and Rabolt J.F. Functionalizing electrospun fibers with biologically relevant macromolecules. Biomacromolecules 6 (2005) 1998-2007
51. Gomes R., Farach-Carson M., and Carson D. Perlecan functions in chondrogenesis: insights from in vitro and in vivo models. Cells Tissues Organs 176 (2004) 79-86
52. Mello M.A., and Tuan R.S. High-density micromass cultures of embryonic limb bud mesenchymal cells: an in vitro model of endochondral skeletal development. In Vitro Cell Dev Biol Anim 35 (1999) 262-269
53. Fisher M.C., Li Y.C., Seghatoleslami M.R., Dealy C.N., and Kosher R.A. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol 25 (2006) 27-39